Moptim announced that it has received marketing clearance from the Food and Drug Administration (FDA), for its manual refractometer the iRef. With this clearance, Moptim continues to deliver the innovative solutions for primary eye care around the world.

iRef, which is already CE-marked approved, offers the low-cost, convenient solution for primary vision care, myopia management, vision screening, and post-operative visual acuity evaluation at home. Its compact and portable design can be used anytime, anywhere. You can also manage your eye care records and track vision changes over time through the mobile application "Eyecare".

Moptim will be showcasing the iRef at the VISION EXPO, held Sept 14-17, 2022 in Las Vegas, Nevada (Booth #F5038) and the ESCRS, held Sept 16-20, 2022 in Milan, Italy (Booth #D63).